PHARMA-SKAN ApS: Financial statements 2012
CVR: 16275247
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 11,585,742 and a net result of DKK 8,351,918. Equity in the 2012 report amounted to DKK 17,603,052. The solvency ratio was 50.5%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 11,585,742
- Profit/Loss
- DKK 8,351,918
- Equity
- DKK 17,603,052
- Total Assets
- DKK 34,871,613
- Employees
- 10
Official annual report
Keep an eye on PHARMA-SKAN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.